Isoray, Inc.
Isoray, Inc. ISR Peers
See (ISR) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ISR | $0.38 | N/A | N/A | N/A | N/A | N/A |
| ABT | $132.00 | -0.93% | 229.66B | 17.14 | $7.70 | +1.73% |
| BSX-PA | $122.18 | +2.37% | 175.45B | 230.53 | $0.53 | N/A |
| BSX | $102.90 | +0.04% | 152.24B | 75.11 | $1.37 | N/A |
| SYK | $388.23 | +1.92% | 148.37B | 52.39 | $7.41 | +0.84% |
| MDT | $85.81 | +2.79% | 110.05B | 26.16 | $3.28 | +3.27% |
| EW | $74.80 | +1.52% | 43.88B | 30.91 | $2.42 | N/A |
| DXCM | $85.05 | +0.45% | 33.35B | 63.95 | $1.33 | N/A |
| PHG | $25.05 | +2.06% | 23.17B | 86.36 | $0.29 | N/A |
| STE | $233.15 | +2.97% | 22.91B | 37.54 | $6.21 | +0.96% |
Stock Comparison
ISR vs ABT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ABT has a market cap of 229.66B. Regarding current trading prices, ISR is priced at $0.38, while ABT trades at $132.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ABT's P/E ratio is 17.14. In terms of profitability, ISR's ROE is -0.49%, compared to ABT's ROE of +0.24%. Regarding short-term risk, ISR is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BSX-PA Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BSX-PA has a market cap of 175.45B. Regarding current trading prices, ISR is priced at $0.38, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ISR's ROE is -0.49%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, ISR is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BSX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BSX has a market cap of 152.24B. Regarding current trading prices, ISR is priced at $0.38, while BSX trades at $102.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BSX's P/E ratio is 75.11. In terms of profitability, ISR's ROE is -0.49%, compared to BSX's ROE of +0.10%. Regarding short-term risk, ISR is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SYK Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SYK has a market cap of 148.37B. Regarding current trading prices, ISR is priced at $0.38, while SYK trades at $388.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SYK's P/E ratio is 52.39. In terms of profitability, ISR's ROE is -0.49%, compared to SYK's ROE of +0.11%. Regarding short-term risk, ISR is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs MDT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, MDT has a market cap of 110.05B. Regarding current trading prices, ISR is priced at $0.38, while MDT trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas MDT's P/E ratio is 26.16. In terms of profitability, ISR's ROE is -0.49%, compared to MDT's ROE of +0.09%. Regarding short-term risk, ISR is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs EW Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, EW has a market cap of 43.88B. Regarding current trading prices, ISR is priced at $0.38, while EW trades at $74.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas EW's P/E ratio is 30.91. In terms of profitability, ISR's ROE is -0.49%, compared to EW's ROE of +0.49%. Regarding short-term risk, ISR is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs DXCM Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, DXCM has a market cap of 33.35B. Regarding current trading prices, ISR is priced at $0.38, while DXCM trades at $85.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas DXCM's P/E ratio is 63.95. In terms of profitability, ISR's ROE is -0.49%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, ISR is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs PHG Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, PHG has a market cap of 23.17B. Regarding current trading prices, ISR is priced at $0.38, while PHG trades at $25.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas PHG's P/E ratio is 86.36. In terms of profitability, ISR's ROE is -0.49%, compared to PHG's ROE of -0.06%. Regarding short-term risk, ISR is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs STE Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, STE has a market cap of 22.91B. Regarding current trading prices, ISR is priced at $0.38, while STE trades at $233.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas STE's P/E ratio is 37.54. In terms of profitability, ISR's ROE is -0.49%, compared to STE's ROE of +0.07%. Regarding short-term risk, ISR is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs PODD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, PODD has a market cap of 22.28B. Regarding current trading prices, ISR is priced at $0.38, while PODD trades at $316.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas PODD's P/E ratio is 54.69. In terms of profitability, ISR's ROE is -0.49%, compared to PODD's ROE of +0.41%. Regarding short-term risk, ISR is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ZBH Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ZBH has a market cap of 19.43B. Regarding current trading prices, ISR is priced at $0.38, while ZBH trades at $98.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ZBH's P/E ratio is 21.83. In terms of profitability, ISR's ROE is -0.49%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, ISR is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ABMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ABMD has a market cap of 17.18B. Regarding current trading prices, ISR is priced at $0.38, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ISR's ROE is -0.49%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ISR is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ALGN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ALGN has a market cap of 13.70B. Regarding current trading prices, ISR is priced at $0.38, while ALGN trades at $189.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ALGN's P/E ratio is 34.43. In terms of profitability, ISR's ROE is -0.49%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, ISR is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SWAV Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SWAV has a market cap of 12.57B. Regarding current trading prices, ISR is priced at $0.38, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ISR's ROE is -0.49%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, ISR is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SNN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SNN has a market cap of 12.44B. Regarding current trading prices, ISR is priced at $0.38, while SNN trades at $28.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SNN's P/E ratio is 30.26. In terms of profitability, ISR's ROE is -0.49%, compared to SNN's ROE of +0.08%. Regarding short-term risk, ISR is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs PEN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, PEN has a market cap of 11.52B. Regarding current trading prices, ISR is priced at $0.38, while PEN trades at $297.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas PEN's P/E ratio is 277.99. In terms of profitability, ISR's ROE is -0.49%, compared to PEN's ROE of +0.04%. Regarding short-term risk, ISR is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs GMED Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, GMED has a market cap of 7.99B. Regarding current trading prices, ISR is priced at $0.38, while GMED trades at $59.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas GMED's P/E ratio is 78.69. In terms of profitability, ISR's ROE is -0.49%, compared to GMED's ROE of +0.03%. Regarding short-term risk, ISR is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BIO Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BIO has a market cap of 7.00B. Regarding current trading prices, ISR is priced at $0.38, while BIO trades at $256.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BIO's P/E ratio is -3.35. In terms of profitability, ISR's ROE is -0.49%, compared to BIO's ROE of -0.32%. Regarding short-term risk, ISR is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BIO-B Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BIO-B has a market cap of 6.33B. Regarding current trading prices, ISR is priced at $0.38, while BIO-B trades at $234.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BIO-B's P/E ratio is -3.06. In terms of profitability, ISR's ROE is -0.49%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, ISR is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BRKR Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BRKR has a market cap of 6.10B. Regarding current trading prices, ISR is priced at $0.38, while BRKR trades at $40.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BRKR's P/E ratio is 77.42. In terms of profitability, ISR's ROE is -0.49%, compared to BRKR's ROE of +0.07%. Regarding short-term risk, ISR is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs GKOS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, GKOS has a market cap of 5.41B. Regarding current trading prices, ISR is priced at $0.38, while GKOS trades at $94.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas GKOS's P/E ratio is -41.72. In terms of profitability, ISR's ROE is -0.49%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, ISR is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs NARI Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, NARI has a market cap of 4.68B. Regarding current trading prices, ISR is priced at $0.38, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas NARI's P/E ratio is -59.24. In terms of profitability, ISR's ROE is -0.49%, compared to NARI's ROE of -0.18%. Regarding short-term risk, ISR is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs INSP Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, INSP has a market cap of 4.61B. Regarding current trading prices, ISR is priced at $0.38, while INSP trades at $156.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas INSP's P/E ratio is 71.43. In terms of profitability, ISR's ROE is -0.49%, compared to INSP's ROE of +0.10%. Regarding short-term risk, ISR is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs IRTC Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, IRTC has a market cap of 4.40B. Regarding current trading prices, ISR is priced at $0.38, while IRTC trades at $137.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas IRTC's P/E ratio is -44.03. In terms of profitability, ISR's ROE is -0.49%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, ISR is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ITGR Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ITGR has a market cap of 4.21B. Regarding current trading prices, ISR is priced at $0.38, while ITGR trades at $120.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ITGR's P/E ratio is 56.09. In terms of profitability, ISR's ROE is -0.49%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, ISR is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs TMDX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, TMDX has a market cap of 4.02B. Regarding current trading prices, ISR is priced at $0.38, while TMDX trades at $118.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas TMDX's P/E ratio is 110.96. In terms of profitability, ISR's ROE is -0.49%, compared to TMDX's ROE of +0.18%. Regarding short-term risk, ISR is less volatile compared to TMDX. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs AXNX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, AXNX has a market cap of 3.63B. Regarding current trading prices, ISR is priced at $0.38, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ISR's ROE is -0.49%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ISR is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs PRCT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, PRCT has a market cap of 3.01B. Regarding current trading prices, ISR is priced at $0.38, while PRCT trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas PRCT's P/E ratio is -32.21. In terms of profitability, ISR's ROE is -0.49%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, ISR is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs LIVN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, LIVN has a market cap of 2.47B. Regarding current trading prices, ISR is priced at $0.38, while LIVN trades at $45.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas LIVN's P/E ratio is -11.11. In terms of profitability, ISR's ROE is -0.49%, compared to LIVN's ROE of +0.05%. Regarding short-term risk, ISR is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs NUVA Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, NUVA has a market cap of 2.08B. Regarding current trading prices, ISR is priced at $0.38, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ISR's ROE is -0.49%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ISR is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs UFPT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, UFPT has a market cap of 1.88B. Regarding current trading prices, ISR is priced at $0.38, while UFPT trades at $244.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas UFPT's P/E ratio is 29.97. In terms of profitability, ISR's ROE is -0.49%, compared to UFPT's ROE of +0.18%. Regarding short-term risk, ISR is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CNMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CNMD has a market cap of 1.88B. Regarding current trading prices, ISR is priced at $0.38, while CNMD trades at $60.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CNMD's P/E ratio is 15.94. In terms of profitability, ISR's ROE is -0.49%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, ISR is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ATEC Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ATEC has a market cap of 1.85B. Regarding current trading prices, ISR is priced at $0.38, while ATEC trades at $12.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ATEC's P/E ratio is -11.11. In terms of profitability, ISR's ROE is -0.49%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, ISR is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs TNDM Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, TNDM has a market cap of 1.56B. Regarding current trading prices, ISR is priced at $0.38, while TNDM trades at $23.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas TNDM's P/E ratio is -8.41. In terms of profitability, ISR's ROE is -0.49%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, ISR is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs HSKA Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, HSKA has a market cap of 1.31B. Regarding current trading prices, ISR is priced at $0.38, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ISR's ROE is -0.49%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ISR is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs AHCO Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, AHCO has a market cap of 1.23B. Regarding current trading prices, ISR is priced at $0.38, while AHCO trades at $9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas AHCO's P/E ratio is 15.71. In terms of profitability, ISR's ROE is -0.49%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, ISR is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs AORT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, AORT has a market cap of 1.23B. Regarding current trading prices, ISR is priced at $0.38, while AORT trades at $28.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas AORT's P/E ratio is -56.43. In terms of profitability, ISR's ROE is -0.49%, compared to AORT's ROE of -0.07%. Regarding short-term risk, ISR is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SILK Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SILK has a market cap of 1.12B. Regarding current trading prices, ISR is priced at $0.38, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SILK's P/E ratio is -18.96. In terms of profitability, ISR's ROE is -0.49%, compared to SILK's ROE of -0.37%. Regarding short-term risk, ISR is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs FNA Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, FNA has a market cap of 1.10B. Regarding current trading prices, ISR is priced at $0.38, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas FNA's P/E ratio is -19.83. In terms of profitability, ISR's ROE is -0.49%, compared to FNA's ROE of -0.36%. Regarding short-term risk, ISR is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs IART Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, IART has a market cap of 1.06B. Regarding current trading prices, ISR is priced at $0.38, while IART trades at $13.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas IART's P/E ratio is -35.97. In terms of profitability, ISR's ROE is -0.49%, compared to IART's ROE of -0.03%. Regarding short-term risk, ISR is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs INMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, INMD has a market cap of 1.04B. Regarding current trading prices, ISR is priced at $0.38, while INMD trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas INMD's P/E ratio is 6.73. In terms of profitability, ISR's ROE is -0.49%, compared to INMD's ROE of +0.25%. Regarding short-term risk, ISR is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ESTA Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ESTA has a market cap of 999.65M. Regarding current trading prices, ISR is priced at $0.38, while ESTA trades at $34.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ESTA's P/E ratio is -11.53. In terms of profitability, ISR's ROE is -0.49%, compared to ESTA's ROE of -1.80%. Regarding short-term risk, ISR is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CSII Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CSII has a market cap of 843.96M. Regarding current trading prices, ISR is priced at $0.38, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CSII's P/E ratio is -20.83. In terms of profitability, ISR's ROE is -0.49%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ISR is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CRY Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CRY has a market cap of 725.15M. Regarding current trading prices, ISR is priced at $0.38, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CRY's P/E ratio is 425.71. In terms of profitability, ISR's ROE is -0.49%, compared to CRY's ROE of -0.07%. Regarding short-term risk, ISR is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SIBN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SIBN has a market cap of 719.58M. Regarding current trading prices, ISR is priced at $0.38, while SIBN trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SIBN's P/E ratio is -22.60. In terms of profitability, ISR's ROE is -0.49%, compared to SIBN's ROE of -0.19%. Regarding short-term risk, ISR is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs IRMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, IRMD has a market cap of 668.43M. Regarding current trading prices, ISR is priced at $0.38, while IRMD trades at $52.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas IRMD's P/E ratio is 33.92. In terms of profitability, ISR's ROE is -0.49%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, ISR is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CBLL Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CBLL has a market cap of 620.21M. Regarding current trading prices, ISR is priced at $0.38, while CBLL trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CBLL's P/E ratio is -5.06. In terms of profitability, ISR's ROE is -0.49%, compared to CBLL's ROE of +0.88%. Regarding short-term risk, ISR is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs AVNS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, AVNS has a market cap of 605.33M. Regarding current trading prices, ISR is priced at $0.38, while AVNS trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas AVNS's P/E ratio is -1.58. In terms of profitability, ISR's ROE is -0.49%, compared to AVNS's ROE of -0.35%. Regarding short-term risk, ISR is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BFLY Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BFLY has a market cap of 581.13M. Regarding current trading prices, ISR is priced at $0.38, while BFLY trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BFLY's P/E ratio is -7.83. In terms of profitability, ISR's ROE is -0.49%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, ISR is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs APEN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, APEN has a market cap of 579.72M. Regarding current trading prices, ISR is priced at $0.38, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas APEN's P/E ratio is -9.43. In terms of profitability, ISR's ROE is -0.49%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ISR is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs KIDS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, KIDS has a market cap of 576.37M. Regarding current trading prices, ISR is priced at $0.38, while KIDS trades at $23.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas KIDS's P/E ratio is -14.19. In terms of profitability, ISR's ROE is -0.49%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, ISR is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs RXST Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, RXST has a market cap of 558.76M. Regarding current trading prices, ISR is priced at $0.38, while RXST trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas RXST's P/E ratio is -19.37. In terms of profitability, ISR's ROE is -0.49%, compared to RXST's ROE of -0.11%. Regarding short-term risk, ISR is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs AXGN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, AXGN has a market cap of 518.75M. Regarding current trading prices, ISR is priced at $0.38, while AXGN trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas AXGN's P/E ratio is -49.52. In terms of profitability, ISR's ROE is -0.49%, compared to AXGN's ROE of -0.10%. Regarding short-term risk, ISR is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs OFIX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, OFIX has a market cap of 487.02M. Regarding current trading prices, ISR is priced at $0.38, while OFIX trades at $12.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas OFIX's P/E ratio is -3.77. In terms of profitability, ISR's ROE is -0.49%, compared to OFIX's ROE of -0.23%. Regarding short-term risk, ISR is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BFLY-WT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BFLY-WT has a market cap of 460.99M. Regarding current trading prices, ISR is priced at $0.38, while BFLY-WT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, ISR's ROE is -0.49%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, ISR is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs TMCI Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, TMCI has a market cap of 452.60M. Regarding current trading prices, ISR is priced at $0.38, while TMCI trades at $7.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas TMCI's P/E ratio is -7.99. In terms of profitability, ISR's ROE is -0.49%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, ISR is less volatile compared to TMCI. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs BVS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BVS has a market cap of 447.25M. Regarding current trading prices, ISR is priced at $0.38, while BVS trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BVS's P/E ratio is -12.96. In terms of profitability, ISR's ROE is -0.49%, compared to BVS's ROE of -0.22%. Regarding short-term risk, ISR is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs NPCE Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, NPCE has a market cap of 437.90M. Regarding current trading prices, ISR is priced at $0.38, while NPCE trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas NPCE's P/E ratio is -14.38. In terms of profitability, ISR's ROE is -0.49%, compared to NPCE's ROE of -2.58%. Regarding short-term risk, ISR is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SENS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SENS has a market cap of 392.64M. Regarding current trading prices, ISR is priced at $0.38, while SENS trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SENS's P/E ratio is -5.00. In terms of profitability, ISR's ROE is -0.49%, compared to SENS's ROE of -5.15%. Regarding short-term risk, ISR is less volatile compared to SENS. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs SRDX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SRDX has a market cap of 387.37M. Regarding current trading prices, ISR is priced at $0.38, while SRDX trades at $27.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SRDX's P/E ratio is -19.35. In terms of profitability, ISR's ROE is -0.49%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, ISR is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CTKB Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CTKB has a market cap of 382.51M. Regarding current trading prices, ISR is priced at $0.38, while CTKB trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CTKB's P/E ratio is -60.40. In terms of profitability, ISR's ROE is -0.49%, compared to CTKB's ROE of -0.02%. Regarding short-term risk, ISR is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CLPT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CLPT has a market cap of 381.64M. Regarding current trading prices, ISR is priced at $0.38, while CLPT trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CLPT's P/E ratio is -19.49. In terms of profitability, ISR's ROE is -0.49%, compared to CLPT's ROE of -0.62%. Regarding short-term risk, ISR is less volatile compared to CLPT. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs NNOX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, NNOX has a market cap of 354.52M. Regarding current trading prices, ISR is priced at $0.38, while NNOX trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas NNOX's P/E ratio is -6.11. In terms of profitability, ISR's ROE is -0.49%, compared to NNOX's ROE of -0.30%. Regarding short-term risk, ISR is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SMLR Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SMLR has a market cap of 334.34M. Regarding current trading prices, ISR is priced at $0.38, while SMLR trades at $34.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SMLR's P/E ratio is 6.79. In terms of profitability, ISR's ROE is -0.49%, compared to SMLR's ROE of +0.35%. Regarding short-term risk, ISR is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs PACB Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, PACB has a market cap of 330.05M. Regarding current trading prices, ISR is priced at $0.38, while PACB trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas PACB's P/E ratio is -0.69. In terms of profitability, ISR's ROE is -0.49%, compared to PACB's ROE of -0.59%. Regarding short-term risk, ISR is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs VREX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, VREX has a market cap of 312.08M. Regarding current trading prices, ISR is priced at $0.38, while VREX trades at $7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas VREX's P/E ratio is -6.43. In terms of profitability, ISR's ROE is -0.49%, compared to VREX's ROE of -0.09%. Regarding short-term risk, ISR is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs OM Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, OM has a market cap of 288.70M. Regarding current trading prices, ISR is priced at $0.38, while OM trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas OM's P/E ratio is -0.44. In terms of profitability, ISR's ROE is -0.49%, compared to OM's ROE of -2.17%. Regarding short-term risk, ISR is less volatile compared to OM. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs CERS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CERS has a market cap of 258.07M. Regarding current trading prices, ISR is priced at $0.38, while CERS trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CERS's P/E ratio is -13.50. In terms of profitability, ISR's ROE is -0.49%, compared to CERS's ROE of -0.35%. Regarding short-term risk, ISR is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs VMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, VMD has a market cap of 257.30M. Regarding current trading prices, ISR is priced at $0.38, while VMD trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas VMD's P/E ratio is 23.25. In terms of profitability, ISR's ROE is -0.49%, compared to VMD's ROE of +0.09%. Regarding short-term risk, ISR is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ZIMV Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ZIMV has a market cap of 248.78M. Regarding current trading prices, ISR is priced at $0.38, while ZIMV trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ZIMV's P/E ratio is -7.24. In terms of profitability, ISR's ROE is -0.49%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, ISR is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs MXCT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, MXCT has a market cap of 241.34M. Regarding current trading prices, ISR is priced at $0.38, while MXCT trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas MXCT's P/E ratio is -5.82. In terms of profitability, ISR's ROE is -0.49%, compared to MXCT's ROE of -0.19%. Regarding short-term risk, ISR is less volatile compared to MXCT. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs TCMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, TCMD has a market cap of 225.97M. Regarding current trading prices, ISR is priced at $0.38, while TCMD trades at $9.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas TCMD's P/E ratio is 14.73. In terms of profitability, ISR's ROE is -0.49%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, ISR is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs NVRO Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, NVRO has a market cap of 224.09M. Regarding current trading prices, ISR is priced at $0.38, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ISR's ROE is -0.49%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ISR is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs QTRX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, QTRX has a market cap of 222.44M. Regarding current trading prices, ISR is priced at $0.38, while QTRX trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas QTRX's P/E ratio is -5.73. In terms of profitability, ISR's ROE is -0.49%, compared to QTRX's ROE of -0.12%. Regarding short-term risk, ISR is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs EYES Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, EYES has a market cap of 210.05M. Regarding current trading prices, ISR is priced at $0.38, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas EYES's P/E ratio is N/A. In terms of profitability, ISR's ROE is -0.49%, compared to EYES's ROE of -0.26%. Regarding short-term risk, ISR is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs MASS Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, MASS has a market cap of 204.79M. Regarding current trading prices, ISR is priced at $0.38, while MASS trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas MASS's P/E ratio is -2.70. In terms of profitability, ISR's ROE is -0.49%, compared to MASS's ROE of -0.52%. Regarding short-term risk, ISR is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ELMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ELMD has a market cap of 192.10M. Regarding current trading prices, ISR is priced at $0.38, while ELMD trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ELMD's P/E ratio is 29.93. In terms of profitability, ISR's ROE is -0.49%, compared to ELMD's ROE of +0.16%. Regarding short-term risk, ISR is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs RCEL Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, RCEL has a market cap of 191.65M. Regarding current trading prices, ISR is priced at $0.38, while RCEL trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas RCEL's P/E ratio is -3.03. In terms of profitability, ISR's ROE is -0.49%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, ISR is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs CATX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CATX has a market cap of 185.13M. Regarding current trading prices, ISR is priced at $0.38, while CATX trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CATX's P/E ratio is -2.05. In terms of profitability, ISR's ROE is -0.49%, compared to CATX's ROE of -0.27%. Regarding short-term risk, ISR is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BDMD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BDMD has a market cap of 183.63M. Regarding current trading prices, ISR is priced at $0.38, while BDMD trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BDMD's P/E ratio is 14.80. In terms of profitability, ISR's ROE is -0.49%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, ISR is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ANIK Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ANIK has a market cap of 169.95M. Regarding current trading prices, ISR is priced at $0.38, while ANIK trades at $11.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ANIK's P/E ratio is -19.75. In terms of profitability, ISR's ROE is -0.49%, compared to ANIK's ROE of -0.30%. Regarding short-term risk, ISR is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs INGN Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, INGN has a market cap of 169.39M. Regarding current trading prices, ISR is priced at $0.38, while INGN trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas INGN's P/E ratio is -4.14. In terms of profitability, ISR's ROE is -0.49%, compared to INGN's ROE of -0.19%. Regarding short-term risk, ISR is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs BWAY Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, BWAY has a market cap of 166.83M. Regarding current trading prices, ISR is priced at $0.38, while BWAY trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas BWAY's P/E ratio is 49.11. In terms of profitability, ISR's ROE is -0.49%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, ISR is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs TLSI Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, TLSI has a market cap of 165.23M. Regarding current trading prices, ISR is priced at $0.38, while TLSI trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas TLSI's P/E ratio is -3.90. In terms of profitability, ISR's ROE is -0.49%, compared to TLSI's ROE of +1.14%. Regarding short-term risk, ISR is less volatile compared to TLSI. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs LNSR Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, LNSR has a market cap of 164.50M. Regarding current trading prices, ISR is priced at $0.38, while LNSR trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas LNSR's P/E ratio is -5.11. In terms of profitability, ISR's ROE is -0.49%, compared to LNSR's ROE of -1.14%. Regarding short-term risk, ISR is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs AVR Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, AVR has a market cap of 162.45M. Regarding current trading prices, ISR is priced at $0.38, while AVR trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas AVR's P/E ratio is -2.28. In terms of profitability, ISR's ROE is -0.49%, compared to AVR's ROE of -4.16%. Regarding short-term risk, ISR is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs SGHT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, SGHT has a market cap of 157.67M. Regarding current trading prices, ISR is priced at $0.38, while SGHT trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas SGHT's P/E ratio is -2.96. In terms of profitability, ISR's ROE is -0.49%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, ISR is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs LUNG Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, LUNG has a market cap of 148.15M. Regarding current trading prices, ISR is priced at $0.38, while LUNG trades at $3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas LUNG's P/E ratio is -2.56. In terms of profitability, ISR's ROE is -0.49%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, ISR is less volatile compared to LUNG. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs PROF Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, PROF has a market cap of 129.38M. Regarding current trading prices, ISR is priced at $0.38, while PROF trades at $4.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas PROF's P/E ratio is -3.84. In terms of profitability, ISR's ROE is -0.49%, compared to PROF's ROE of -0.62%. Regarding short-term risk, ISR is less volatile compared to PROF. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs RPID Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, RPID has a market cap of 127.98M. Regarding current trading prices, ISR is priced at $0.38, while RPID trades at $2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas RPID's P/E ratio is -2.70. In terms of profitability, ISR's ROE is -0.49%, compared to RPID's ROE of -0.52%. Regarding short-term risk, ISR is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs CVRX Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, CVRX has a market cap of 123.77M. Regarding current trading prices, ISR is priced at $0.38, while CVRX trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas CVRX's P/E ratio is -1.79. In terms of profitability, ISR's ROE is -0.49%, compared to CVRX's ROE of -0.93%. Regarding short-term risk, ISR is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs MYO Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, MYO has a market cap of 118.73M. Regarding current trading prices, ISR is priced at $0.38, while MYO trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas MYO's P/E ratio is -20.62. In terms of profitability, ISR's ROE is -0.49%, compared to MYO's ROE of -0.45%. Regarding short-term risk, ISR is more volatile compared to MYO. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs LUCD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, LUCD has a market cap of 115.92M. Regarding current trading prices, ISR is priced at $0.38, while LUCD trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas LUCD's P/E ratio is -1.05. In terms of profitability, ISR's ROE is -0.49%, compared to LUCD's ROE of -4.60%. Regarding short-term risk, ISR is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ICAD Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ICAD has a market cap of 101.82M. Regarding current trading prices, ISR is priced at $0.38, while ICAD trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ICAD's P/E ratio is -17.67. In terms of profitability, ISR's ROE is -0.49%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, ISR is less volatile compared to ICAD. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs HJLI Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, HJLI has a market cap of 98.32M. Regarding current trading prices, ISR is priced at $0.38, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas HJLI's P/E ratio is N/A. In terms of profitability, ISR's ROE is -0.49%, compared to HJLI's ROE of -0.51%. Regarding short-term risk, ISR is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs ASXC Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, ASXC has a market cap of 94.92M. Regarding current trading prices, ISR is priced at $0.38, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas ASXC's P/E ratio is -1.12. In terms of profitability, ISR's ROE is -0.49%, compared to ASXC's ROE of -4.07%. Regarding short-term risk, ISR is more volatile compared to ASXC. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs MGRM Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, MGRM has a market cap of 92.81M. Regarding current trading prices, ISR is priced at $0.38, while MGRM trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas MGRM's P/E ratio is -5.16. In terms of profitability, ISR's ROE is -0.49%, compared to MGRM's ROE of -1.29%. Regarding short-term risk, ISR is less volatile compared to MGRM. This indicates potentially lower risk in terms of short-term price fluctuations for ISR.
ISR vs QIPT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, QIPT has a market cap of 91.78M. Regarding current trading prices, ISR is priced at $0.38, while QIPT trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas QIPT's P/E ratio is -14.20. In terms of profitability, ISR's ROE is -0.49%, compared to QIPT's ROE of -0.07%. Regarding short-term risk, ISR is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.
ISR vs OWLT Comparison
ISR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISR stands at N/A. In comparison, OWLT has a market cap of 85.52M. Regarding current trading prices, ISR is priced at $0.38, while OWLT trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISR currently has a P/E ratio of N/A, whereas OWLT's P/E ratio is -3.30. In terms of profitability, ISR's ROE is -0.49%, compared to OWLT's ROE of +0.65%. Regarding short-term risk, ISR is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for ISR.